Volume 28, Supplement—December 2022
SUPPLEMENT ISSUE
Clinical
Effects of COVID-19 on Vaccine-Preventable Disease Surveillance Systems in the World Health Organization African Region, 2020
John Paul Bigouette
, Anna W. Callaghan, Morgane Donadel, Angela Montesanti Porter, Louie Rosencrans, Jacquelyn S. Lickness, Sara Blough, Xi Li, Robert T. Perry, A.J. Williams, Heather M. Scobie, Benjamin A. Dahl, Jeffrey McFarland, and Christopher S. Murrill
, Anna W. Callaghan, Morgane Donadel, Angela Montesanti Porter, Louie Rosencrans, Jacquelyn S. Lickness, Sara Blough, Xi Li, Robert T. Perry, A.J. Williams, Heather M. Scobie, Benjamin A. Dahl, Jeffrey McFarland, and Christopher S. Murrill
Table 1
Characteristics of 154 STOP Program consultants in the World Health Organization’s African Region who responded to a survey on the effects of COVID-19 on vaccine-preventable disease surveillance systems, 2020*
| Characteristics | Value† |
|---|---|
| Number of countries with STOP respondents |
27 (57) |
| Median number of STOP respondents per country (IQR) |
4 (2–8) |
| STOP consultant administrative level of assignment‡ | |
| National | 30 (19) |
| Provincial | 53 (34) |
| District | 64 (42) |
| Local |
7 (5) |
| STOP consultant role | |
| Field epidemiologist | 107 (70) |
| Communication specialists | 26 (17) |
| Data manager | 21 (14) |
*Values are no. (%) except as indicated. IQR, interquartile range.
†Percentages may not equal 100% because of rounding.
‡Deployment location at time of survey response.
Page created: August 25, 2022
Page updated: December 11, 2022
Page reviewed: December 11, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.